Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
Heart disease is the number-one killer of women, with over 60 million women (44%) in the U.S. living with some form of heart disease. There is one woman dying from heart disease every minute. The ...